Individually Tailored Balance Training for Older Adults at Risk of Falling (STABLERCT)
Specific Training According to BaLance Evaluation (STABLE) Versus the Otago Exercise Program for Older Adults With Impaired Balance in Cross-sectoral Rehabilitation: A Double-blind Randomized Controlled Trial
The goal of this clinical trial is to learn whether individually tailored balance training based on the STABLE approach (Specific Training According to BaLance Evaluation) prevents falls better than the Otago Exercise Program in older adults with impaired balance. STABLE uses five simple clinical tests to build a balance profile, from which a physical therapist selects a few home exercises aimed at the person's main balance problems. The main question it aims to answer is: Does STABLE reduce the proportion of participants who fall at least once during the 26 weeks after the training period, compared with the Otago Exercise Program? Researchers will also compare number of falls, injurious falls, hospital admissions, mortality, balance and gait performance, fear of falling, dizziness, physical activity and quality of life.
Participants will:
- be randomized to STABLE or to the Otago Exercise Program (supplemented with gaze stabilization exercises if they have vestibular dysfunction)
- perform supervised home exercises for 3 to 4 months with 2 to 6 follow-up physical therapy consultations at the hospital or in their municipal rehabilitation center
- complete a balance and gait test before and after the training period, measured with a body-worn movement sensor and a force plate
- answer a short text message (SMS) questionnaire about falls once a week for 26 weeks after the training period Hospital admissions and mortality are collected from medical records 6 and again 24 months after the end of training. Participants' and physical therapists' experiences of the two approaches are explored in qualitative interviews.
Visão geral do estudo
Status
Status
Condições
Condições
Intervenção / Tratamento
Intervenção / Tratamento
Descrição detalhada
Falls among older adults are common and costly, and exercise, including balance training, reduces the rate of falls, but existing programs have shown only small reductions in the number of people who fall. The Otago Exercise Program (OEP) is the most widely used home-based falls prevention program, but it is only partly tailored to the individual. STABLE is a new approach in which five clinical tests, each measuring a specific balance domain (limits of stability, sensory orientation, reactive stepping, power and turning), form a balance profile that guides the choice of a few targeted home exercises. In a cohort study, 40% fewer patients fell within six months after STABLE-based rehabilitation, but STABLE has not been tested in a controlled trial.
This is a double-blind (participant and outcome assessor), two-arm, parallel-group randomized controlled trial with 1:1 allocation. Over two years, 552 older adults referred for physical therapy assessment of balance at Herlev and Gentofte Hospital or Rigshospitalet, Denmark, are included. Randomization is stratified by the including physical therapist, history of falls before inclusion and planned follow-up setting (hospital or municipality), using randomly permuted blocks of 4 and 6, and is performed automatically in REDCap. Participants receive 3 to 4 months of supervised home exercise according to allocation, followed up at the hospital or in participating municipal rehabilitation centers. A blinded tester measures gait (inertial sensor), standing balance, sit-to-stand power and reach (force plate) and patient-reported outcomes before and after the intervention. Falls are recorded with a weekly SMS questionnaire for 26 weeks after the end-of-treatment test; hospital admissions and mortality are collected from medical records at 6 and 24 months. The primary outcome is the proportion of participants who fall at least once during the 26 weeks, analyzed by intention to treat with multiple imputation. A qualitative study explores participants' and physical therapists' experiences.
Tipo de estudo
Tipo de estudo
Inscrição (Estimado)
Inscrição
Estágio
Estágio
- Não aplicável
Contactos e Locais
Contato de estudo
Contato de estudo
- Nome: Kasper Søndergaard, PhD
- Número de telefone: 004531317026
- E-mail: kasper.soendergaard@regionh.dk
Estude backup de contato
- Nome: Carsten Bogh Juhl, PhD, Professor
- Número de telefone: 004521395639
- E-mail: Carsten.Bogh.Juhl@regionh.dk
Locais de estudo
-
-
-
Herlev, Dinamarca, 2730
- Genoptræning og Forebyggelse, Herlev Kommune
-
Contato:
- Charlotte G Sommer, BSc
- Número de telefone: 004521397834
- E-mail: HK56397@herlev.dk
-
Rødovre Municipality, Dinamarca, 2610
- Genoptræning, Rødovre Kommune
-
Contato:
- Henriette W Bjerrum, BSc
- Número de telefone: 004520418153
- E-mail: cn26232@rk.dk
-
Ølstykke, Dinamarca, 3650
- Sundhed og omsorg, Egedal kommune
-
Contato:
- Lone K Eriksen, BSc
- Número de telefone: 004572596729
- E-mail: Lone.K.Eriksen@egekom.dk
-
-
Region Sjælland
-
Copenhagen, Region Sjælland, Dinamarca, 2100
- Copenhagen University Hospital - Rigshospitalet
-
Contato:
- Kasper Søndergaard, PhD
- Número de telefone: 004531317026
- E-mail: kasper.soendergaard@regionh.dk
-
Contato:
- Måns H Magnusson, Professor
- E-mail: mehem@dtu.dk
-
Subinvestigador:
- Stefania Serafin, Professor
-
Hellerup, Region Sjælland, Dinamarca, 2900
- Copenhagen University Hospital - Herlev and Gentofte Hospital
-
Contato:
- Kasper Søndergaard, PhD
- Número de telefone: 004531317026
- E-mail: kasper.soendergaard@regionh.dk
-
Contato:
- Carsten Bogh Juhl, Professor
- Número de telefone: 004521395639
- E-mail: Carsten.Bogh.Juhl@regionh.dk
-
Investigador principal:
- Kasper Søndergaard, PhD
-
Subinvestigador:
- Carsten B Juhl, Professor
-
Subinvestigador:
- Anders M Vinther, PhD
-
Subinvestigador:
- Jesper Ryg, Professor
-
-
Critérios de participação
Critérios de elegibilidade
Critérios de elegibilidade
Idades elegíveis para estudo
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Descrição
Inclusion Criteria:
- Referred to physical therapy assessment of balance at Herlev and Gentofte Hospital or Rigshospitalet
- Aged 65 years or older
- Impaired balance at the physical therapy assessment
- Judged able to carry out home-based self-training
- Living in a participating municipality (Rødovre, Herlev or Egedal), or, if living elsewhere, judged by the physical therapist to be best rehabilitated with follow-up at the hospital
Exclusion Criteria:
- Significant cognitive or language limitations preventing self-training or informed consent
- Declines rehabilitation or participation in the study
- No balance problems at the physical therapy assessment
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Prevenção
- Alocação: Randomizado
- Modelo Intervencional: Atribuição Paralela
- Mascaramento: Triplo
Número de braços
Armas e Intervenções
Grupo de Participantes / BraçoGrupo de Participantes / Braço |
Intervenção / TratamentoIntervenção / Tratamento |
|---|---|
|
Experimental: STABLE
Individually tailored home exercise based on the STABLE approach. Exercises are selected from the five STABLE test scores, the patient's goals and overall health condition, typically targeting the primary balance limitations at an appropriate level of difficulty. 3 to 4 months of home exercise with 2 to 6 follow-up physical therapy consultations in which exercises are adjusted. |
Specific Training According to BaLance Evaluation (STABLE) is centered on five clinical tests (Maximal reach test [Meach], Test of Reference frame Interaction in Balance [TRIB], Reactive Four Square Step Test [RFSST], Adjusted Sit To Stand test [ASTS], Turn And Touch test [TAT]) measuring five balance domains (limits of stability, sensory orientation, reactive stepping, power, turning) form a balance profile used together with the patient's goals and health condition to select a few targeted home exercises (https://godbalance.dk/). Instructed by a physical therapist at the hospital and followed up at the hospital or in the municipal rehabilitation center for 3 to 4 months.
Outros nomes:
|
|
Comparador Ativo: Otago Exercise Program
Home exercise according to the Otago Exercise Program. The level is chosen from the 30-second chair stand test and the 4-Stage Balance Test. Participants with vestibular dysfunction are also instructed in gaze stabilization exercises (GSE). Same number and schedule of follow-up consultations as the STABLE arm. |
Otago Exercise Program (OEP) is a standardized home-based strength and balance program (https://www.livestronger.org.nz/assets/Uploads/acc1162-otago-exercise-manual.pdf). Level chosen from the 30-second chair stand test and the 4-Stage Balance Test. Participants with vestibular dysfunction additionally receive gaze stabilization exercises. Same delivery and follow-up as the STABLE arm.
Outros nomes:
|
O que o estudo está medindo?
Medidas de resultados primários
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Proportion of participants who fall at least once
Prazo: Weekly for 26 weeks after the end-of-treatment test (approximately 3 to 5 months after baseline)
|
A fall is defined as an unexpected event in which the participant comes to rest on the ground, floor or lower level, regardless of cause or consequence. Recorded with a weekly SMS questionnaire ("Have you fallen since you last answered this questionnaire?"). Each answer covers all weeks from the previous answer. A fall-related hospital admission in the medical record also counts as a fall. Participants are classified as non-fallers only if all answers are "no", week 26 is answered and no fall-related admission is recorded. Others with incomplete data are imputed. The test SMS sent at the end-of-treatment test does not count. Participants who cannot receive SMS report falls via a relative's phone, or via a paper fall diary returned by post supplemented by a telephone call at 6 months. |
Weekly for 26 weeks after the end-of-treatment test (approximately 3 to 5 months after baseline)
|
Medidas de resultados secundários
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Number of falls
Prazo: 26 weeks after the end-of-treatment test
|
Total number of falls reported in the weekly SMS (1 to 10, or more than 10, per answer), at least the number of fall-related admissions in the medical record, analyzed as a rate per week covered. |
26 weeks after the end-of-treatment test
|
|
Number of falls with loss of consciousness
Prazo: 26 weeks after the end-of-treatment test
|
Self-reported in the weekly SMS questionnaire (reason for falling). |
26 weeks after the end-of-treatment test
|
|
Number of falls with fracture
Prazo: 26 weeks after the end-of-treatment test
|
Self-reported in the weekly SMS questionnaire. |
26 weeks after the end-of-treatment test
|
|
Hospital admissions
Prazo: 6 and 24 months after the end-of-treatment test
|
Number of all-cause and fall-related hospital admissions, from medical records. |
6 and 24 months after the end-of-treatment test
|
|
Mortality
Prazo: 6 and 24 months after the end-of-treatment test
|
Vital status and date of death, from medical records. |
6 and 24 months after the end-of-treatment test
|
|
Rehabilitation courses
Prazo: 6 and 24 months after the end-of-treatment test
|
Number of subsequent rehabilitation courses, from medical records. |
6 and 24 months after the end-of-treatment test
|
|
Gait performance and movement quality
Prazo: Baseline and end of treatment (approximately 3 to 5 months after baseline)
|
Seven walking tasks measured with an inertial sensor (Cometa WaveTrack) on the lower back: Timed Up and Go, 3-meter walk, line walking, foam walking with eyes open and closed, figure-of-eight walk and walking over an obstacle. Outcomes: task duration (s), log dimensionless jerk (LDLJ-A), spectral arc length (SPARC), root mean square acceleration (anteroposterior, mediolateral, vertical) and turning velocity. Fastest trial of two per task. |
Baseline and end of treatment (approximately 3 to 5 months after baseline)
|
|
Postural sway
Prazo: Baseline and end of treatment (approximately 3 to 5 months after baseline)
|
Modified Clinical Test of Sensory Interaction on Balance (firm and foam surface, eyes open and closed, 40 s each) on a force plate (AMTI AccuSway). Centre of pressure (COP) sway measures (e.g. RMS, velocity, sway area) from the middle 30 s, and loss of balance. |
Baseline and end of treatment (approximately 3 to 5 months after baseline)
|
|
Sit-to-stand power
Prazo: Baseline and end of treatment (approximately 3 to 5 months after baseline)
|
Peak power during a fast sit-to-stand on the force plate (body weight × vertical displacement / time). Best of 2 trials. |
Baseline and end of treatment (approximately 3 to 5 months after baseline)
|
|
Forward reach (limits of stability)
Prazo: Baseline and end of treatment (approximately 3 to 5 months after baseline)
|
Maximal anterior COP displacement during forward reach on the force plate, expressed as a percentage of the distance from the posterior edge of the medial malleolus to the tip of the big toe. Best of 2 trials. |
Baseline and end of treatment (approximately 3 to 5 months after baseline)
|
|
STABLE test scores
Prazo: Initial physical therapy assessment and final physical therapy assessment (approximately 3 to 4 months later)
|
Scores on the five STABLE tests (Mreach, TRIB, RFSST, ASTS, TAT). Not blinded at the final physical therapy assessment. Assessment not blinded. |
Initial physical therapy assessment and final physical therapy assessment (approximately 3 to 4 months later)
|
|
Dynamic Gait Index (DGI)
Prazo: Initial physical therapy assessment and final physical therapy assessment (approximately 3 to 4 months later)
|
Score 0 to 24, higher is better. Not blinded at the final physical therapy assessment. Assessment not blinded. |
Initial physical therapy assessment and final physical therapy assessment (approximately 3 to 4 months later)
|
|
4-Stage Balance Test (FSB)
Prazo: Initial physical therapy assessment and final physical therapy assessment (approximately 3 to 4 months later)
|
Score 0 to 40, higher is better. Not blinded at the final physical therapy assessment. Assessment not blinded. |
Initial physical therapy assessment and final physical therapy assessment (approximately 3 to 4 months later)
|
|
30-second chair stand test (30STS)
Prazo: Initial physical therapy assessment and final physical therapy assessment (approximately 3 to 4 months later)
|
Score 0 and above, higher is better. Not blinded at the final physical therapy assessment. Assessment not blinded. |
Initial physical therapy assessment and final physical therapy assessment (approximately 3 to 4 months later)
|
|
Fear of falling
Prazo: Baseline and end of treatment (approximately 3 to 5 months after baseline)
|
Falls Efficacy Scale-International (FES-I), 16 to 64, higher is more concern. |
Baseline and end of treatment (approximately 3 to 5 months after baseline)
|
|
Dizziness handicap
Prazo: Baseline and end of treatment (approximately 3 to 5 months after baseline)
|
Dizziness Handicap Inventory (DHI), 0 to 100, higher is more handicap. |
Baseline and end of treatment (approximately 3 to 5 months after baseline)
|
|
Physical activity
Prazo: Baseline and end of treatment (approximately 3 to 5 months after baseline)
|
Physical Activity Scale for the Elderly (PASE). |
Baseline and end of treatment (approximately 3 to 5 months after baseline)
|
|
Health-related quality of life
Prazo: Baseline and end of treatment (approximately 3 to 5 months after baseline)
|
EQ-5D-5L index and EQ VAS. |
Baseline and end of treatment (approximately 3 to 5 months after baseline)
|
|
Patient-reported global change and tailoring
Prazo: End of treatment (approximately 3 to 5 months after baseline)
|
Perceived overall change in balance and/or dizziness, perceived tailoring of home exercises and continuity between assessment and exercises (5-point scales). |
End of treatment (approximately 3 to 5 months after baseline)
|
Outras medidas de resultado
Outras medidas de resultado
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Physical therapists' use of test results
Prazo: Final physical therapy assessment (approximately 3 to 4 months after the initial assessment)
|
Questions answered by the municipal physical therapist at the final assessment of each participant: "Did you use the test results to select or adjust exercises?" (5-point Likert scale). |
Final physical therapy assessment (approximately 3 to 4 months after the initial assessment)
|
|
Exercise adherence
Prazo: Final physical therapy assessment (approximately 3 to 4 months after the initial assessment)
|
Self-reported adherence to home exercise (4-point scale), number of exercise sessions per week and duration. |
Final physical therapy assessment (approximately 3 to 4 months after the initial assessment)
|
|
Adverse effects during exercise
Prazo: End of treatment (approximately 3 to 5 months after baseline)
|
Frequency, intensity and duration of pain and dizziness during home exercise, falls during exercise, and worsening or new health problems during the training period |
End of treatment (approximately 3 to 5 months after baseline)
|
Colaboradores e Investigadores
Patrocinador
Patrocinador
Colaboradores
Colaboradores
Investigadores
Investigadores
- Investigador principal: Kasper Søndergaard, PhD, Copenhagen University Hospital - Herlev and Gentofte and Copenhagen University Hospital - Rigshospitalet
Publicações e links úteis
Links úteis
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Estimado)
Início do estudo
Conclusão Primária (Estimado)
Conclusão Primária
Conclusão do estudo (Estimado)
Conclusão do estudo
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Primeira postagem
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última Atualização Postada
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Última verificação
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
Outros números de identificação do estudo
- STABLE-RCT-2026
- H-26038898 (Outro identificador: The Scientific Ethics Committee of the Capital Region of Denmark)
- p-2026-21537 (Outro identificador: Research Legal Office, Capital Region of Denmark)
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
Descrição do plano IPD
Individual participant data are not shared publicly, as this is not covered by the ethics and data protection approvals and is restricted by the EU General Data Protection Regulation (GDPR).
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .